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and could be considered identical cohorts with similar pain
intensity. For the evaluation of dose developments mean daily
dosages of the ﬁrst and last prescribed patches were calculated
and compared. RESULTS: In all patients, the prescribed mean
daily doses increased during therapy. However, this increase 
was more pronounced in patients on TD fentanyl treatment. 
The mean percentile intra-individual increases per day in cancer
patients were up to 0.42% and 0.17% in the TD fentanyl and
TD buprenorphine patients, respectively, and in non-cancer
patients to 0.25% for TD fentanyl and 0.09% for TD buprenor-
phine. The higher dose increase in TD fentanyl patients was 
statistically signiﬁcant (p < 0.0001) and could not be explained
by co-medication or titration. CONCLUSIONS: The analyses
were conducted on identical cohort patients with similar pain
intensity, expecting similar drug utilization patterns for TD
buprenorphine and TD fentanyl. The lower increase of the mean
daily doses in TD buprenorphine patients suggests a higher 
tolerance development with TD fentanyl compared to TD
buprenorphine.
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OBJECTIVE: To determine the factor structure of the Beck
Depression Inventory (BDI) in a chronic pain population. The
factor structure will be discussed in the context of assessing
depression in pain. METHODS: The BDI was administered to a
convenience sample of 128 patients who had experienced pain
for a duration of at least three-months. The BDI is a 21 item
instrument; however, for the purposes of this study one item
assessing suicidal ideation was deleted. Conﬁrmatory factor
analysis using maximum likelihood estimation techniques were
run for several published factor structures of the BDI that have
been evaluated in pain patients. RESULTS: The average score on
the BDI for this sample was 20.54 (s.d. = 8.8). Based on a single
factor score, 25% (n = 32), 23.4% (n = 30), 14.1% (n = 18) and
1.6% (n = 2) of the sample was classiﬁed with borderline clini-
cal depression, moderate depression, severe depression, and
extreme depression respectively. Results from the factor analysis
suggest that various two and three factor solutions provide 
adequate ﬁt to the data. A two factor solution comprising items
that reﬂect negative view of the self and impaired physical func-
tion provided best ﬁt to the data. The chi-square statistic calcu-
lated for this model was 75.45 based on 64 degrees of freedom
(p = 0.15). Patients provided low scores on the negative view 
of self factor (mean = 4.39, s.d. = 3.65) and high scores on the
impaired physical function factor (mean = 9.12, s.d. = 3.44).
CONCLUSION: Pain has a signiﬁcant negative impact on a
variety of functions. However, pain patients do not exhibit the
cognitive biases displayed by patients diagnosed with major
depressive disorder.
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OBJECTIVES: Measuring back pain for further clinical research
required the linguistic validation of a nine-item questionnaire
developed in US English. Based on the assumption that the orig-
inal concepts were universally appropriate, we aimed to develop
language versions of a US back pain questionnaire according to
a rigorous methodology to ensure the conceptual equivalence
between the original and the translations. METHODS: The
process was conducted by a specialist in each target country
using the following standardized methodology: 1) two forward
translations by professional translators, native speakers of the
target language and ﬂuent in English; 2) comparison and recon-
ciliation of the translations by the specialist in the target country
and the translators; 3) backward translation by a native English
speaker; 4) comparison of source and backward version; and 5)
comprehension test on ﬁve individuals suffering from back pain
and review by one clinician. RESULTS: Issues regarding the uni-
versal appropriateness of the original concepts emerged during
the creation of the 35 language versions. Items investigating the
respondent’s ability to get in and out of his car had to be refor-
mulated in countries where the ownership of cars was rare. 
Similarly for countries in which people did not wear socks or
stockings an alternative question had to be found. CONCLU-
SION: The 35 language versions were established according 
to a rigorous translation methodology. The process ensured 
the conceptual equivalence of all language versions to facilitate
the international comparison and pooling of data. This process
also reveals that the original concepts are not necessarily uni-
versally appropriate. This indicates the necessity to integrate
international feedback on concepts before the original question-
naire is ﬁnalized to facilitate the cross-cultural equivalence of
concepts.
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OBJECTIVE: Pain in persons at the end of life has not yet been
well described. The purpose of this study is to describe the occur-
rence of severe pain among persons who received hospice care
in the US. METHODS: Data for this study were derived from a
database developed by excelleRx Incorporated, which provides
pharmacy services to US hospices. The excelleRx database
includes demographic and clinical data for persons during the
period from February 1, 2000—July 26, 2004. Worst pain inten-
sity during the previous 24 hours is assessed using a zero—ten
numeric rating scale (NRS; zero = none, ten = worst) by hospice
nurses periodically during a person’s hospice admission.
RESULTS: Of 326,737 persons who received hospice care in 419
US hospices during the study period, severe pain (NRS
seven–ten) was reported at least once by 20.3% of persons with
at least one pain score. Of these individuals, mean age of persons
who died during hospice care was 68.9 years (median 70.7, SD
14.4), median length of service was 42.0 days, 53.7% were
female, 78.0% were Caucasian, 7.4% were cared for in LTC hos-
pices, and 73.9% had a primary diagnosis of cancer. Within the
subset of persons who reported severe pain and were treated in
a long-term-care hospice, 66.8% were female, 78.1% were Cau-
casian, and 47.6% had a primary diagnosis of cancer. CON-
CLUSION: Severe pain was reported at least once by a
substantial percentage of persons in this cohort, of those indi-
viduals cared for in long-term-care facilities, and of persons with
a primary diagnosis of cancer. These data provide insight into
improving the care of persons at the end of life.
